828 related items for PubMed ID: 28320400
1. Predictors for intravenous immunoglobulin resistance and coronary artery lesions in Kawasaki disease.
Xie T, Wang Y, Fu S, Wang W, Xie C, Zhang Y, Gong F.
Pediatr Rheumatol Online J; 2017 Mar 21; 15(1):17. PubMed ID: 28320400
[Abstract] [Full Text] [Related]
2. Evaluation of intravenous immunoglobulin resistance and coronary artery lesions in relation to Th1/Th2 cytokine profiles in patients with Kawasaki disease.
Wang Y, Wang W, Gong F, Fu S, Zhang Q, Hu J, Qi Y, Xie C, Zhang Y.
Arthritis Rheum; 2013 Mar 21; 65(3):805-14. PubMed ID: 23440694
[Abstract] [Full Text] [Related]
3. Delayed intravenous immunoglobulin treatment increased the risk of coronary artery lesions in children with Kawasaki disease at different status.
Qiu H, He Y, Rong X, Ren Y, Pan L, Chu M, Wu R, Shi H.
Postgrad Med; 2018 May 21; 130(4):442-447. PubMed ID: 29745742
[Abstract] [Full Text] [Related]
4. A comparison of serum IL6 and CRP levels with respect to coronary changes and treatment response in Kawasaki disease patients: a prospective study.
Nandi A, Pal P, Basu S.
Rheumatol Int; 2019 Oct 21; 39(10):1797-1801. PubMed ID: 31302740
[Abstract] [Full Text] [Related]
5. N-terminal pro-brain natriuretic peptide and risk of coronary artery lesions and resistance to intravenous immunoglobulin in Kawasaki disease.
Yoshimura K, Kimata T, Mine K, Uchiyama T, Tsuji S, Kaneko K.
J Pediatr; 2013 Jun 21; 162(6):1205-9. PubMed ID: 23290510
[Abstract] [Full Text] [Related]
6. A Comprehensive Assessment of the Value of Laboratory Indices in Diagnosing Kawasaki Disease.
Ye Q, Shao WX, Shang SQ, Zhang T, Hu J, Zhang CC.
Arthritis Rheumatol; 2015 Jul 21; 67(7):1943-50. PubMed ID: 25778686
[Abstract] [Full Text] [Related]
7. Predictive value of monocyte to HDL-C ratio for coronary artery lesions and intravenous immunoglobulin resistance in Kawasaki disease.
Wang JR, Zhao HZ, Chang LJ, Xu X, Gao Y, Li M, Kong QY, Wang MM, Zhao CF.
Eur J Pediatr; 2023 Oct 21; 182(10):4399-4406. PubMed ID: 37480545
[Abstract] [Full Text] [Related]
8. The role of age-specific N-terminal pro-brain natriuretic peptide cutoff values in predicting intravenous immunoglobulin resistance in Kawasaki disease: a prospective cohort study.
Shao S, Luo C, Zhou K, Hua Y, Wu M, Liu L, Liu X, Wang C.
Pediatr Rheumatol Online J; 2019 Sep 18; 17(1):65. PubMed ID: 31533770
[Abstract] [Full Text] [Related]
9. Serum amyloid A as a biomarker for immunoglobulin resistance in Kawasaki disease.
Huang XB, Zhao S, Liu ZY, Xu YY, Deng F.
Ann Med; 2023 Sep 18; 55(2):2264315. PubMed ID: 37870383
[Abstract] [Full Text] [Related]
10. The role of serum lipid in predicting coronary artery lesions and intravenous immunoglobulin resistance in Kawasaki disease: a cohort study.
Zhang H, Cai J, Zhang R, Shuai S, Tang M, Ju R, Hu Y, Zuo T, Yang Y.
J Int Med Res; 2024 May 18; 52(5):3000605241252115. PubMed ID: 38713460
[Abstract] [Full Text] [Related]
11. Predictive Value of Serum Lipid for Intravenous Immunoglobulin Resistance and Coronary Artery Lesion in Kawasaki Disease.
Shao S, Zhou K, Liu X, Liu L, Wu M, Deng Y, Duan H, Li Y, Hua Y, Wang C.
J Clin Endocrinol Metab; 2021 Sep 27; 106(10):e4210-e4220. PubMed ID: 33837779
[Abstract] [Full Text] [Related]
12. [Prediction of the risk of coronary arterial lesions in Kawasaki disease by N-terminal pro-brain natriuretic peptide].
Huiling L, Yaping L, Xiufen H.
Zhonghua Er Ke Za Zhi; 2015 Apr 27; 53(4):300-3. PubMed ID: 26182507
[Abstract] [Full Text] [Related]
13. N-terminal pro-brain natriuretic peptide (NT proBNP) as a predictive indicator of initial intravenous immunoglobulin treatment failure in children with Kawasaki disease: a retrospective study.
Kim SY, Han MY, Cha SH, Jeon YB.
Pediatr Cardiol; 2013 Apr 27; 34(8):1837-43. PubMed ID: 23744100
[Abstract] [Full Text] [Related]
14. Biomarkers of intravenous immunoglobulin resistance and coronary artery lesions in Kawasaki disease.
Kong WX, Ma FY, Fu SL, Wang W, Xie CH, Zhang YY, Gong FQ.
World J Pediatr; 2019 Apr 27; 15(2):168-175. PubMed ID: 30809758
[Abstract] [Full Text] [Related]
15. Serum IL-41 might be a biomarker for IVIG resistance and coronary artery lesions in Kawasaki disease.
Duan Y, Li H, Luo D, Jiang J, Liu B, Li G.
Int Immunopharmacol; 2023 Sep 27; 122():110600. PubMed ID: 37423157
[Abstract] [Full Text] [Related]
16. Inflammatory cytokines as predictors of resistance to intravenous immunoglobulin therapy in Kawasaki disease patients.
Sato S, Kawashima H, Kashiwagi Y, Hoshika A.
Int J Rheum Dis; 2013 Apr 27; 16(2):168-72. PubMed ID: 23773640
[Abstract] [Full Text] [Related]
17. Risk factors of intravenous immunoglobulin resistance and coronary arterial lesions in Turkish children with Kawasaki disease.
Türkuçar S, Yıldız K, Acarı C, Dundar HA, Kır M, Ünsal E.
Turk J Pediatr; 2020 Apr 27; 62(1):1-9. PubMed ID: 32253860
[Abstract] [Full Text] [Related]
18. Interleukin-6 is prone to be a candidate biomarker for predicting incomplete and IVIG nonresponsive Kawasaki disease rather than coronary artery aneurysm.
Wu Y, Liu FF, Xu Y, Wang JJ, Samadli S, Wu YF, Liu HH, Chen WX, Luo HH, Zhang DD, Wei W, Hu P.
Clin Exp Med; 2019 May 27; 19(2):173-181. PubMed ID: 30617865
[Abstract] [Full Text] [Related]
19. Clinically useful predictors of resistance to intravenous immunoglobulin and prognosis of coronary artery lesions in patients with incomplete kawasaki disease.
Cho KH, Kang SJ.
Korean Circ J; 2014 Sep 27; 44(5):328-35. PubMed ID: 25278986
[Abstract] [Full Text] [Related]
20. Importance of C-reactive protein level in predicting non-response to additional intravenous immunoglobulin treatment in children with Kawasaki disease: a retrospective study.
Iwashima S, Kimura M, Ishikawa T, Ohzeki T.
Clin Drug Investig; 2011 Sep 27; 31(3):191-9. PubMed ID: 21456105
[Abstract] [Full Text] [Related]
Page: [Next] [New Search]
